These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 3857527

  • 1. In vitro activity of timentin.
    Thomas MG, Lang SD.
    N Z Med J; 1985 May 22; 98(779):403-4. PubMed ID: 3857527
    [No Abstract] [Full Text] [Related]

  • 2. Sensitivity of clinical bacterial isolates to Timentin (ticarcillin/clavulanic acid).
    Villiger JW.
    N Z Med J; 1986 Nov 26; 99(814):914. PubMed ID: 3492692
    [No Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of piperacillin v timentin and ticarcillin.
    Bremner DA.
    N Z Med J; 1987 May 13; 100(823):299-300. PubMed ID: 3138579
    [No Abstract] [Full Text] [Related]

  • 4. In vitro activity and disk susceptibility of Timentin: current status.
    Fuchs PC, Barry AL, Jones RN.
    Am J Med; 1985 Nov 29; 79(5B):25-32. PubMed ID: 4073092
    [No Abstract] [Full Text] [Related]

  • 5. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
    Griffin KE, Slocombe B.
    J Chemother; 1989 Jul 29; 1(4 Suppl):267-9. PubMed ID: 16312396
    [No Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
    Holder IA, Vanderpool L, Wesselman J.
    J Burn Care Rehabil; 1985 Jul 29; 6(4):331-4. PubMed ID: 3879938
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of timentin in intensive care].
    Gérard A, Dureux JB, Canton P, May T, Schmit JL.
    Pathol Biol (Paris); 1986 May 29; 34(5):448-50. PubMed ID: 3534719
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of parenteral ticarcillin formulated with clavulanic acid: Timentin.
    Staniforth DH, Coates PE, Davies BE, Horton R.
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar 29; 24(3):123-9. PubMed ID: 3699938
    [Abstract] [Full Text] [Related]

  • 9. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
    Joly B, Chanal M, Sirot D, Cluzel M, Sirot J, Cluzel R.
    J Antimicrob Chemother; 1986 May 29; 17 Suppl C():27-33. PubMed ID: 3522530
    [Abstract] [Full Text] [Related]

  • 10. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C, Kitzis M, Le Mée J.
    Pathol Biol (Paris); 1986 Apr 29; 34(4):245-8. PubMed ID: 3528998
    [Abstract] [Full Text] [Related]

  • 11. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D, Le Noc P, Robert J.
    Pathol Biol (Paris); 1985 Jun 29; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
    Chattopadhyay B, Hall I.
    Curr Med Res Opin; 1984 Jun 29; 9(3):157-60. PubMed ID: 6568146
    [Abstract] [Full Text] [Related]

  • 13. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH, Spohr M.
    Chemotherapy; 1987 Jun 29; 33(5):340-6. PubMed ID: 3117502
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.
    Barry AL, Ayers LW, Gavan TL, Gerlach EH, Jones RN.
    Eur J Clin Microbiol; 1984 Jun 29; 3(3):203-6. PubMed ID: 6147246
    [Abstract] [Full Text] [Related]

  • 15. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
    Campos P, Vera A, Martin-Luengo F.
    Chemioterapia; 1987 Jun 29; 6(2 Suppl):77-8. PubMed ID: 3151358
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clavulanic acid/antibiotic ratios.
    Rolinson GN.
    J Antimicrob Chemother; 1985 Feb 29; 15(2):256-7. PubMed ID: 3980316
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Susceptibility testing recommendations for ticarcillin/clavulanic acid in the Stokes' disc diffusion test.
    Sutherland R.
    J Antimicrob Chemother; 1989 Sep 29; 24(3):463-4. PubMed ID: 2808198
    [No Abstract] [Full Text] [Related]

  • 20. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC, Jones RN, Barry AL, Thornsberry C.
    J Clin Microbiol; 1984 Apr 29; 19(4):555-7. PubMed ID: 6715524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.